The EU-European Union drug regulator has not yet officially approved the new coronavirus drug being developed by US pharmaceutical giant Pfizer, but it can be used by adults at high risk of becoming severe in emergencies. Announced the view that.

Within the EU, there is growing concern about the spread of infection with the new coronavirus mutated virus, Omicron strain, and each country is under pressure to take measures such as tightening regulations.



EU drug regulatory agency, EMA = European Medicines Agency, on the 16th, a drug to suppress the growth of the new coronavirus under development by American pharmaceutical giant Pfizer can be used for adults at high risk of becoming severe in emergencies etc. Announced the view that.



Although the EMA has not yet officially approved the drug for sale, it has verified the data so far that it can reduce the risk of hospitalization and death if it is started within 5 days of the onset of symptoms. increase.



Now that the EMA's views have been presented, each EU member state will decide whether to actually use this drug.



EMA announced last month that it can also be used in emergencies, etc., for the oral medicine developed by the American pharmaceutical giant "Merck".